<VariationArchive RecordType="classified" VariationID="11319" VariationName="NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)" VariationType="Deletion" Accession="VCV000011319" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-10-07" DateCreated="2016-04-16" MostRecentSubmission="2023-10-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26358" VariationID="11319">
      <GeneList>
        <Gene Symbol="TIMM8A" FullName="translocase of inner mitochondrial membrane 8A" GeneID="1678" HGNC_ID="HGNC:11817" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101345661" stop="101348742" display_start="101345661" display_stop="101348742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100600643" stop="100603956" display_start="100600643" display_stop="100603956" Strand="-" />
          </Location>
          <OMIM>300356</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TIMM8A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TIMM8A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)</Name>
      <CanonicalSPDI>NC_000023.11:101346635:GCCCAGGCTTG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100601624" stop="100601633" display_start="100601624" display_stop="100601633" variantLength="10" positionVCF="100601623" referenceAlleleVCF="GGCCCAGGCTT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101346636" stop="101346645" display_start="101346636" display_stop="101346645" variantLength="10" positionVCF="101346635" referenceAlleleVCF="GGCCCAGGCTT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K50fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.100601625_100601634del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.100601625_100601634del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.101346637_101346646del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.101346637_101346646del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011734.1" sequenceAccession="NG_011734" sequenceVersion="1" change="g.7325_7334del">
            <Expression>NG_011734.1:g.7325_7334del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145951.2" sequenceAccession="NM_001145951" sequenceVersion="2" change="c.*1742_*1751del">
            <Expression>NM_001145951.2:c.*1742_*1751del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004085.4" sequenceAccession="NM_004085" sequenceVersion="4" change="c.148_157del" MANESelect="true">
            <Expression>NM_004085.4:c.148_157del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004076.1" sequenceAccession="NP_004076" sequenceVersion="1" change="p.Lys50fs">
            <Expression>NP_004076.1:p.Lys50fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA358688" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300356.0002" DB="OMIM" />
        <XRef Type="rs" ID="869320733" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 8841189 Fig. 3b to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs) AND Deafness dystonia syndrome" Accession="RCV000012071" Version="5">
        <ClassifiedConditionList TraitSetID="3102">
          <ClassifiedCondition DB="MedGen" ID="C0796074">Deafness dystonia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-04-16" MostRecentSubmission="2023-10-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8841189</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3102" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3213" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Deafness dystonia syndrome</ElementValue>
                <XRef ID="MONDO:0010578" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness syndrome, progressive, with blindness, dystonia, fractures, and mental deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness-dystonia-optic atrophy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness-dystonia-optic neuronopathy (DDON) syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DDON syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Jensen syndrome</ElementValue>
                <XRef ID="Jensen+syndrome/3902" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Opticoacustic nerve atrophy with dementia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nerve deafness optic nerve atrophy, and dementia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Syndrome of opticoacoustic nerve atrophy with dementia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness-Dystonia-Optic Neuronopathy Syndrome</ElementValue>
                <XRef ID="NBK1216" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTONIA-DEAFNESS SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="304700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mohr-Tranebjaerg syndrome</ElementValue>
                <XRef ID="Mohr-Tranebjaerg+syndrome/4848" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA</ElementValue>
                <XRef Type="MIM" ID="304700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DDSX</ElementValue>
                <XRef Type="MIM" ID="304700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MTS</ElementValue>
                <XRef Type="MIM" ID="304700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DDP</ElementValue>
                <XRef Type="MIM" ID="304700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be consistent in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia.</Attribute>
                <XRef ID="NBK1216" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8331" />
                <XRef ID="8331" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301395</ID>
                <ID Source="BookShelf">NBK1216</ID>
              </Citation>
              <XRef ID="52368" DB="Orphanet" />
              <XRef ID="C0796074" DB="MedGen" />
              <XRef ID="MONDO:0010578" DB="MONDO" />
              <XRef Type="MIM" ID="304700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7562985" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="45656|OMIM:304700" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004041491" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004085.4:c.148_157del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="304700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858663</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32305" SubmissionDate="2016-04-14" DateLastUpdated="2016-04-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300356.0002_MOHR-TRANEBJAERG SYNDROME" title="TIMM8A, 10-BP DEL, FS61TER_MOHR-TRANEBJAERG SYNDROME" />
        <ClinVarAccession Accession="SCV000032305" DateUpdated="2016-04-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In pedigree K8190 segregating for sensorineural deafness and dystonia (MTS; 304700) and the symptom of mental deficiency, Jin et al. (1996) found a 10-bp deletion in exon 2 of the DDP gene. This mutation created a frameshift that resulted in the addition of 12 novel amino acids after the methionine residue at codon 48, followed by polypeptide termination.</Attribute>
              <Citation>
                <ID Source="PubMed">8841189</ID>
              </Citation>
              <XRef DB="OMIM" ID="304700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TIMM8A" />
          </GeneList>
          <Name>TIMM8A, 10-BP DEL, FS61TER</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">10-BP DEL, FS61TER</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300356.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MOHR-TRANEBJAERG SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32305" TraitType="Disease" MappingType="Name" MappingValue="MOHR-TRANEBJAERG SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0796074" Name="Deafness dystonia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7562985" TraitType="Disease" MappingType="XRef" MappingValue="304700" MappingRef="OMIM">
        <MedGen CUI="C0796074" Name="Deafness dystonia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

